Cariprazine
| CAS No. | 839712-12-8 | Cat. No. | BCP14691 |
| Name | Cariprazine | ||
| Synonyms | RGH-188; RGH188; RGH 188; MP-214; MP 214; MP214; | ||
| Formula | C21H32Cl2N4O | M. Wt | 427.41 |
| Description | Cariprazine, also known as RGH-188 and MP-214, is an antipsychotic drug received FDA approval on September 17, 2015. Cariprazine acts as a D2 and D3 receptor partial agonist, with high selectivity towards the D3 receptor. Action on the dopaminergic systems makes it also potentially useful as an add-on therapy in major depressive disorder. Cariprazine is approved for schizophrenia and bipolar disorder. It has also been investigated as a potential adjunct in treatment-resistant major depressive disorder. | ||
| Pathways | Neuro Signaling Pathway GPCR/G Protein | ||
| Targets | Dopamine Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.